Related Experiment Video
Updated: May 18, 2026

09:07
Techniques of Endoscopic Ossiculoplasty
Published on: January 26, 2024
Total ossiculoplasty: advantages of two-point stabilization technique
Leonard Berenholz1, John Burkey, William Lippy
1The Lippy Group, 3893 E. Market Street, Warren, OH 44484, USA.
International Journal of Otolaryngology
|September 12, 2012
Summary
This study shows that a porous polyethylene prosthesis with two-point stabilization in total ossiculoplasty surgery significantly improves hearing outcomes. The technique, using lateral cartilage and medial areolar tissue grafts, offers a high success rate for chronic ear disease.
Area of Science:
- Otolaryngology
- Biomaterials Science
- Surgical Innovation
Background:
- Total ossiculoplasty aims to restore hearing in patients with ossicular chain discontinuity.
- Traditional ossicular reconstruction methods have varying success rates.
- A novel two-point stabilization technique for total ossicular prostheses (TOP) was developed.
Purpose of the Study:
- To evaluate the efficacy of a porous polyethylene prosthesis with two-point stabilization in total ossiculoplasty.
- To assess the audiological outcomes and stability of this surgical technique.
Main Methods:
- Retrospective cohort review of 50 total ossiculoplasty patients (2004-2007).
- Utilized a porous polyethylene prosthesis with lateral cartilage and medial areolar tissue grafts for stabilization.
- Mean follow-up of 8.1 months with audiological assessment.
Main Results:
- 44% of patients achieved an air-bone gap (ABG) closure within 10 dB; 66% within 20 dB.
- Mean four-frequency hearing gain was 15.7 dB.
- Mean postoperative ABG was 15.7 dB.
Conclusions:
- Two-point stabilization in total ossiculoplasty using porous polyethylene prostheses yields favorable audiological results.
- The combination of lateral cartilage and medial areolar tissue grafts is crucial for prosthesis stability and successful hearing restoration.
- This technique demonstrates superior outcomes compared to existing literature for chronic ear disease management.

